Par Drugs and Chemicals (NSE:PAR) EPS (Basic) : ₹12.54 (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals EPS (Basic)?

Par Drugs and Chemicals's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹0.47. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹12.54.

Par Drugs and Chemicals's EPS (Diluted) for the three months ended in Dec. 2024 was ₹0.47. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹12.54.

Par Drugs and Chemicals's EPS without NRI for the three months ended in Dec. 2024 was ₹0.47. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 13.20.

During the past 12 months, Par Drugs and Chemicals's average EPS without NRIGrowth Rate was 15.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Par Drugs and Chemicals's highest 3-Year average EPS without NRI Growth Rate was 88.70% per year. The lowest was 15.10% per year. And the median was 37.00% per year.

Par Drugs and Chemicals EPS (Basic) Historical Data

The historical data trend for Par Drugs and Chemicals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals EPS (Basic) Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

3.88

9.44

7.49

9.21

11.78

Par Drugs and Chemicals Quarterly Data
	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															2.78	3.02	2.06	6.99	0.47

Par Drugs and Chemicals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Par Drugs and Chemicals's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(145.01	-	0)	/	12.305
	=	11.78

Par Drugs and Chemicals's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(5.78	-	0)	/	12.298
	=	0.47

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹12.54

Par Drugs and Chemicals (NSE:PAR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Par Drugs and Chemicals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Par Drugs and Chemicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website

https://www.pardrugs.com

Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.